Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Elite Pharmaceuticals Inc. (ELTP) had Cost of Goods Sold of $30.27M for the most recently reported fiscal year, ending 2024-03-31.
| Income Statement Financials | |
$56.63M |
|
$20.11M |
|
|
Cost of Goods Sold |
$30.27M |
$26.36M |
|
$45.84M |
|
$10.79M |
|
$-10.33M |
|
$0.46M |
|
$0.46M |
|
$20.11M |
|
$20.11M |
|
$20.11M |
|
$20.11M |
|
$10.79M |
|
$12.26M |
|
1.02B |
|
1.02B |
|
$0.02 |
|
$0.02 |
|
| Balance Sheet Financials | |
$40.01M |
|
$10.18M |
|
$43.64M |
|
$83.65M |
|
$13.05M |
|
$4.76M |
|
$13.02M |
|
$26.07M |
|
$57.58M |
|
$51.24M |
|
$57.58M |
|
1.07B |
|
| Cash Flow Statement Financials | |
$-3.28M |
|
$-0.81M |
|
$3.39M |
|
$8.24M |
|
$7.54M |
|
$-0.71M |
|
$8.51M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.07 |
|
-- |
|
-- |
|
0.08 |
|
0.16 |
|
46.55% |
|
19.05% |
|
19.05% |
|
21.65% |
|
0.82% |
|
35.51% |
|
$-4.09M |
|
-- |
|
-- |
|
-- |
|
0.68 |
|
2.34 |
|
2.91 |
|
125.39 |
|
34.92% |
|
39.24% |
|
24.04% |
|
32.25% |
|
$0.05 |
|
$-0.00 |
|
$-0.00 |
|